Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas
<p>Supplemental figure correlating biological variance ratio (BVR) to contrast-to-variance ratio (CVR).</p>
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1852020836694753280 |
|---|---|
| author | Kimberley S. Samkoe (20877828) |
| author2 | Hira Shahzad Sardar (21233329) Jason R. Gunn (21233332) Jonathan Thomas Elliott (21233335) Sally Mansur (21233338) Joachim Feldwisch (21233341) Brian W. Pogue (17534777) Konstantinos Linos (21233344) Keith D. Paulsen (17534780) Eric R. Henderson (21233347) |
| author2_role | author author author author author author author author author |
| author_facet | Kimberley S. Samkoe (20877828) Hira Shahzad Sardar (21233329) Jason R. Gunn (21233332) Jonathan Thomas Elliott (21233335) Sally Mansur (21233338) Joachim Feldwisch (21233341) Brian W. Pogue (17534777) Konstantinos Linos (21233344) Keith D. Paulsen (17534780) Eric R. Henderson (21233347) |
| author_role | author |
| dc.creator.none.fl_str_mv | Kimberley S. Samkoe (20877828) Hira Shahzad Sardar (21233329) Jason R. Gunn (21233332) Jonathan Thomas Elliott (21233335) Sally Mansur (21233338) Joachim Feldwisch (21233341) Brian W. Pogue (17534777) Konstantinos Linos (21233344) Keith D. Paulsen (17534780) Eric R. Henderson (21233347) |
| dc.date.none.fl_str_mv | 2025-05-02T07:22:42Z |
| dc.identifier.none.fl_str_mv | 10.1158/1535-7163.28918006 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Figure_S3_from_First-in-Human_Study_of_ABY-029_a_Novel_Fluorescent_Peptide_that_Targets_EGFR_Applied_to_Soft-Tissue_Sarcomas/28918006 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biological Agents & Therapies Antireceptors Clinical Imaging Clinical Trial Results Engineering Imaging Imaging probes Sarcomas Soft-tissue sarcoma |
| dc.title.none.fl_str_mv | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Supplemental figure correlating biological variance ratio (BVR) to contrast-to-variance ratio (CVR).</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_43fbf855ffa1ac5d3d3eac4d6d2a24fd |
| identifier_str_mv | 10.1158/1535-7163.28918006 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/28918006 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue SarcomasKimberley S. Samkoe (20877828)Hira Shahzad Sardar (21233329)Jason R. Gunn (21233332)Jonathan Thomas Elliott (21233335)Sally Mansur (21233338)Joachim Feldwisch (21233341)Brian W. Pogue (17534777)Konstantinos Linos (21233344)Keith D. Paulsen (17534780)Eric R. Henderson (21233347)CancerCancer Detection and DiagnosisTherapeutic Research and DevelopmentClinical Research and TrialsMethods and TechnologyBiological Agents & TherapiesAntireceptorsClinical ImagingClinical Trial ResultsEngineeringImagingImaging probesSarcomasSoft-tissue sarcoma<p>Supplemental figure correlating biological variance ratio (BVR) to contrast-to-variance ratio (CVR).</p>2025-05-02T07:22:42ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1535-7163.28918006https://figshare.com/articles/figure/Figure_S3_from_First-in-Human_Study_of_ABY-029_a_Novel_Fluorescent_Peptide_that_Targets_EGFR_Applied_to_Soft-Tissue_Sarcomas/28918006CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/289180062025-05-02T07:22:42Z |
| spellingShingle | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas Kimberley S. Samkoe (20877828) Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biological Agents & Therapies Antireceptors Clinical Imaging Clinical Trial Results Engineering Imaging Imaging probes Sarcomas Soft-tissue sarcoma |
| status_str | publishedVersion |
| title | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| title_full | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| title_fullStr | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| title_full_unstemmed | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| title_short | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| title_sort | Figure S3 from First-in-Human Study of ABY-029, a Novel Fluorescent Peptide that Targets EGFR, Applied to Soft-Tissue Sarcomas |
| topic | Cancer Cancer Detection and Diagnosis Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biological Agents & Therapies Antireceptors Clinical Imaging Clinical Trial Results Engineering Imaging Imaging probes Sarcomas Soft-tissue sarcoma |